drugset / Trial / NCT06510062

Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation

NCT06510062

Phase 1 Completed 67 enrolled ZetrOZ, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation

Timeline

Start
2024-07-22
Primary completion
2024-09-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 2.5 % Topical

Indications

No indication recorded.